Drug-induced bruxism. Algorithm of diagnosis and treatment

Read full text
Authors: Marina I. Soykher, M G Soykher, L. R. Mingazova, Д. А. Трунин, V. V. Govenko
Cited by: 0
References: 16

Abstract

The polyetiology and diversity of manifestations of bruxism, which is accompanied by increased muscle activity, cause certain difficulties in choosing treatment methods. When analyzing recent systematic reviews of the literature on cases of drug-induced bruxism, the most common side effect in the form of jaw clenching occurred when taking selective serotonin reuptake inhibitors, especially fluoxetine, venlafaxine, and sertraline. The lack of a unified methodological approach to the diagnosis and treatment of patients with bruxism, including drug-induced bruxism, makes it difficult to plan treatment measures and prevent the development of this pathological condition. Therefore, therapy in such cases is symptomatic and aimed at preventing damage to the dental and maxillofacial system and orthopedic structures.

Fields of Study & Subjects

Inflammatory Myopathies and Dermatomyositis Botulinum Toxin and Related Neurological Disorders Thallium and Germanium Studies

Publication details

Journal / source
Medical alphabet
Publisher
Alfmed LLC
Issue
30
Pages
54–61
Publication date
3 January 2026